Immunity in pancreatic cancer via il-33 signaling

HIGHLIGHTS

  • who: Targeting TNF-u03b1-producing macrophages et al. from the DepartmentUniversity of Minneapolis, Minnesota, USA have published the article: immunity in pancreatic cancer via IL-33 signaling, in the Journal: (JOURNAL)
  • what: In summary, the study reports heterogeneous TAM populations that originate from bone marrow that are the primary source of TNF-u03b1.
  • how: Normally distributed 2-group data were analyzed using a 2-tailed t test (for 2 groups) or 1-way ANOVA (for multiple comparisons).

SUMMARY

    Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?